ArticleCurrent cancer reports2024

Risk of severe immune-related adverse events in cancer patients with pre-existing autoimmunity receiving immune checkpoint inhibitor therapy.

Dayna Jill Isaacs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.